A Phase 2, Randomized, Placebo-Controlled, Double-Blind, Adaptive, Parallel Group Clinical Study to Evaluate the Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery
Clinical Trial Grant
Administered By
Anesthesiology, Cardiothoracic
Awarded By
Guard Therapeutics International AB
Start Date
February 21, 2023
End Date
January 17, 2024
Administered By
Anesthesiology, Cardiothoracic
Awarded By
Guard Therapeutics International AB
Start Date
February 21, 2023
End Date
January 17, 2024